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Podocyte-like cell with filtration  
slit diaphragm in insects
Although the fully developed nephron has long been regarded as 
a vertebrate adaptation, ‘nephron-like’ features can be found in the 
excretory systems of many invertebrates. In vertebrates, the podo-
cytes in the glomerular filtration barrier send out interdigitating 
foot processes to enwrap the glomerular capillaries. These processes 
are separated by 30- to 50-nm-wide slit pores spanned by the slit 
diaphragm that, together with the glomerular basement membrane, 
form a size- and charge-selective filtration barrier. The invertebrate 
excretory systems contain filtration cells and ducts in which the 
filtrate is modified, and insect nephrocytes regulate hemolymph 
composition by filtration, followed by endocytosis and processing to 
sequester and/or secondarily metabolize toxic materials (Figure). In 
Drosophila, nephrocytes are tethered to the esophagus or heart and 
are bathed in hemolymph, and extensive infolding of their plasma 
membrane generates a network of labyrinthine channels or lacu-
nae flanked by nephrocyte foot processes. The channel entrances 
are narrow slits 30 nm in width, spanned by a single or double 
filament forming a specialized filtration junction—the nephrocyte 
diaphragm. The similarities between the anatomies of the nephro-
cyte and podocyte filtration barriers led Weavers et al. to investigate 
whether the nephrocyte diaphragm is molecularly related to the 
slit diaphragm. In Drosophila melanogaster, they found that ortho-
logues of the major constituents of the slit diaphragm, including 
nephrin, NEPH1, CD2-associated protein, zonula occludens-1, 
and podocin, were expressed in the nephrocyte and form a com-
plex of interacting proteins that closely mirrors the vertebrate slit 
diaphragm complex. Furthermore, they found that the nephrocyte 
diaphragm was completely lost in flies lacking the orthologues of 
nephrin or NEPH1—a phenotype resembling loss of the slit dia-
phragm in the absence of either nephrin or NEPH1. The similarities 
between invertebrate nephrocytes and vertebrate podocytes suggest 
that the two cell types are evolutionarily related and establish the 
nephrocyte as a simple model in which to study podocyte biology 
and podocyte-associated diseases. (Nature advance online publica-
tion, 29 October 2008; doi:10.1038/nature07526)
Juan Oliver
Irbesartan in patients with heart failure 
and preserved ejection fraction
Trials have shown that angiotensin-converting enzyme inhibitors 
(ACEIs) and angiotensin receptor blockers (ARBs) improve cardi-
ovascular outcomes in several populations without kidney disease. 
However, investigations of these agents in patients on dialysis have 
yielded conflicting results. Early data in a trial of dialysis patients 
suggested that an ACEI lowered mortality,1 whereas a later study 
demonstrated that patients with kidney disease did not benefit 
as much as patients with normal kidney function.2 Now, a new 
study by Massie et al. evaluates the effect of the ACEI irbesartan 
among patients with heart failure and preserved ejection fraction. 
More than 4000 subjects at least 60 years of age with class II, III, 
or IV heart failure and an ejection fraction of at least 45% were 
randomly assigned to receive 300 mg of irbesartan or placebo per 
day. The primary outcome of death from any cause or hospitali-
zation for a cardiovascular cause occurred in 742 patients in the 
irbesartan group and 763 in the placebo group (95% confidence 
interval (CI), 0.86–1.05; P = 0.35). The hazard ratio was 1.00 (95% 
CI, 0.88–1.14; P = 0.98) for mortality and 0.95 (95% CI, 0.85–1.08; 
P = 0.44) for hospitalization.
Conclusions from this trial of patients with normal kidney func-
tion cannot be applied to patients on dialysis. However, they reveal 
that acute heart failure is an outcome instead of a disease or syn-
drome, and that treatments likely do not function similarly across 
all etiologies. Therefore, the cause of the heart failure needs to be 
considered carefully before a treatment is chosen or a trial design 
is formulated. (N Engl J Med 2008; 359: 2456–2467; doi:10.1056/
NEJMoa0805450)
Lynda Szczech
1Am J Kidney Dis 2008; 52: 501–506. 2Kidney Int 2006; 70: 1318–1324.
A new renal NH3 transporter
Renal ammonium production and excretion are essential for net 
acid excretion in organisms that generate hydrogen (H+) from their 
diet. Along the nephron, ammonium is produced in proximal tubu-
lar cells, secreted into the proximal urine, then reabsorbed in the 
thick ascending limb of the loop of Henle. Approximately 80% of 
the ammonium produced in the proximal tubule is finally secreted 
into the urine by the collecting duct. Since initially described, the 
process of transepithelial transport of ammonium in the collecting 
duct has been thought to occur through non-ionic NH3 diffusion 
across the lipid bilayer. NH3 is then trapped as NH4+ in the lumen 
of the collecting duct by buffering protons secreted throughout 
ATPases present at the apical membrane of acid-secreting inter-
calated cells. However, ammonium transporter proteins have been 
described in microorganisms; the Mep-Amt family of ammonium 
transporters, in particular, was identified in yeast but also found in 
other microorganisms as well as plants and invertebrates. Although 
these proteins are absent in vertebrates, Rhesus (Rh) factors have 
Schematic drawings of the (a) vertebrate nephron, (b) glomerular filtration 
barrier, (c) insect excretory system, and (d) nephrocyte filtration barrier. 
Ultrafiltration (red arrows), filtrate flow (black arrows), and urinary space  
(b, asterisks) or extracellular lacunae (d, asterisks) are shown. bm, basement 
membrane; fp, foot process; nd, nephrocyte diaphragm; sd, slit diaphragm.
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previously been shown to be related to proteins of the Mep-Amt 
family and could correspond to their yet-to-be-described verte-
brate counterpart. The main Rh antigen (RHD) was identified 
decades ago, but the physiological role of Rhesus-type proteins 
remains unknown. However, several functional expression studies 
indicate that Rh proteins can function as ammonium transporters. 
Human Rh factors comprise blood-group antigens, their associated 
glycoprotein, and two non-erythroid members (Rhbg and Rhcg), 
which are found in the distal nephron. In the acid-secreting inter-
calated cells of the mouse kidney, basolateral Rhbg coexists with 
apical Rhcg. But genetic ablation of mouse Rhbg did not impair 
renal ammonium excretion, nor did it yield a phenotype. In a new 
study, Biver et al. targeted the Rhcg gene in mice and found that 
the Rhcg protein is required for urinary ammonium excretion. 
H4CL acid load in wild-type mice induced a transient decrease of 
blood pH and bicarbonate levels with partial recovery 6 days later 
because of adaptation. In contrast, in Rhcg–/– mice, the decrease 
in blood pH and bicarbonate levels lasted throughout the entire 
treatment, indicating an impaired ability to cope with the acid load. 
Further, nonrenal acid excretion was lower in Rhcg–/– mice because 
of a defect in ammoniuria. The authors also found that the net 
tubular epithelial permeability to NH3 was impaired in Rhcg–/– 
mice (Figure). Thus, during urinary acidification and ammonium 
excretion, Rhcg acts as an ammonium transporter, which mediates 
the net flux of NH3 in the collecting ducts. This elegant study leads 
to a new model of renal ammonium excretion wherein NH3 is at 
least in part translocated through a protein-mediated pathway, and 
not only through simple non-ionic diffusion and subsequent lumi-
nal trapping, as previously thought. (Nature 2008; 456: 339–343; 
doi:10.1038/nature07518)
Qais Al-Awqati
Rac1 GTPase regulates the 
mineralocorticoid receptor  
and affects proteinuria
The mineralocorticoid receptor has a major pathophysiological 
role in the progression of kidney diseases and inhibition of its sig-
naling reduces proteinuria. Recent studies have shown cross-talk 
between steroid receptors and intracellular signaling pathways. 
One such example is their interaction with the Rho family of 
small guanosine triphosphate (GTP)ases; Rho family members 
and their regulatory proteins are involved in the transactivation 
of several steroid receptors. In a recent study, Shibata et al. exam-
ined the possibility that Rho GTPases could influence the func-
tion of the mineralocorticoid receptor. They found that Rac1, 
a member of the Rho family of GTPases, is a potent activator 
of mineralocorticoid receptor signal transduction both in vitro 
and in vivo. Transfection assays in cultured human embryonic 
kidney cells revealed that constitutively active Rac1 (CA-Rac1) 
enhanced mineralocorticoid receptor-dependent reporter activ-
ity, which was accompanied by increased nuclear translocation 
of mineralocorticoid receptor. Also, CA-Rac1 facilitated min-
eralocorticoid receptor nuclear accumulation in podocytes via 
p21-activated kinase phosphorylation. To perform in vivo experi-
ments, the authors made use of the fact that Rho GDP dissocia-
tion inhibitor (RhoGDI) interacts with the GDP-bound inactive 
Rho GTPases and prevents them from being converted to the 
active GTP-bound forms. Three distinct isoforms of RhoGDI 
exist in mammals: GDI-α, GDI-β, and GDI-γ. Among these, they 
suspected that RhoGDI-α could have a major role in the kidney, 
because mice with deletion of its gene (Arhgdia–/– mice) develop 
progressive renal disease. They found that Arhgdia–/– mice had 
mild albuminuria but unselective proteinuria by approximately 4 
weeks of age. Renal histology at 1 week of age was normal by light 
microscopy, but transmission electron microscopy revealed focal 
effacement of the podocyte foot processes. At 12 weeks of age, 
Arhgdia–/– mice had massive albuminuria and glomerular lesions 
with focal and segmental sclerosis (Figure). These findings were 
associated with increased Rac1 (but not RhoA) and mineralo-
corticoid receptor signaling in the kidney, without alteration in 
systemic aldosterone. In addition, use of a Rac-specific inhibitor 
diminished mineralocorticoid receptor overactivity and renal 
damage. Finally, both histological changes and albuminuria in 
Arhgdia–/– mice were suppressed by mineralocorticoid receptor 
blockade. These results indicate an important regulating effect of 
Rac1 on mineralocorticoid receptor activity and identify Rac1 as 
a potential therapeutic target for chronic kidney and other organ 
diseases. (Nat Med 2008; 14: 1370–1376; doi:10.1038/nm.1879)
Juan Oliver 
Isolated cortical collecting ducts (CCD) and outer medullary collecting 
ducts (OMCD) in vitro. Left: Alkalinization (that is, NH3 entry) and 
acidification (NH4
+ entry) rates in CCD and OMCD cells. The reduced rate 
of alkalinization in Rhcg–/– cells indicates impaired luminal NH3 entry. 
Right: NH3 permeability across Rhcg
–/– CCD epithelium was strongly 
impaired compared with wild type.
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Kidneys of wild-type (WT) and Arhgdia–/– mice at 12 weeks of age. 
Arhgdia–/– mice showed focal and segmental glomerulosclerosis  
with prominent proteinaceous casts and tubular dilatation.
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